1. Home
  2. DSS vs BFRI Comparison

DSS vs BFRI Comparison

Compare DSS & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSS

DSS Inc.

HOLD

Current Price

$0.52

Market Cap

5.3M

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.91

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
BFRI
Founded
1984
1997
Country
United States
United States
Employees
102
94
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
13.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DSS
BFRI
Price
$0.52
$0.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
107.2K
183.7K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
42.45
N/A
EPS
N/A
N/A
Revenue
$2,085,000.00
N/A
Revenue This Year
$1.21
$14.36
Revenue Next Year
N/A
$16.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.54
52 Week High
$1.90
$1.19

Technical Indicators

Market Signals
Indicator
DSS
BFRI
Relative Strength Index (RSI) 32.68 33.47
Support Level N/A $0.79
Resistance Level $1.04 $0.93
Average True Range (ATR) 0.04 0.08
MACD 0.00 -0.03
Stochastic Oscillator 11.25 2.97

Price Performance

Historical Comparison
DSS
BFRI

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: